TELO
Telomir Pharmaceuticals, Inc.
0.5950
+0.02 (+2.73%)
52w low 0.5450
1.58 high
4.8% of range
Financial Analysis
| (USD) | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 754.32K | 7.33M | 7.29M | 5.56M | 5.17M | |
| Current Assets | 829.61K | 7.40M | 7.34M | 5.79M | 5.37M | |
| Total Assets | 829.61K | 7.40M | 7.34M | 5.79M | 5.37M | |
| Current Liabilities | 348.39K | 422.81K | 1.43M | 827.31K | 332.42K | |
| Total Liabilities | 348.39K | 422.81K | 1.43M | 827.31K | 332.42K | |
| Retained Earnings | -37.85M | -38.95M | -41.01M | -42.00M | -43.72M | |
| Shareholders Equity | 481.22K | 6.98M | 5.91M | 4.96M | 5.03M | |
| Working Capital | 481.22K | 6.98M | 5.91M | 4.96M | 5.03M | |
| Shares Outstanding | 30.51M | 33.83M | 34.38M | 34.38M | 68.77M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--